DCF — ST. JOSEPHS MEDICAL CENTER
Enterprise Value: $-59.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-59.1M
Enterprise Value
$-26.2M
PV of Cash Flows
$-32.9M
PV of Terminal Value
$-53.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $291.8M | $1.4M | 0.0% | $-10.9M | $-9.9M |
| Year 2 | $300.6M | $4.5M | 1.0% | $-8.3M | $-6.8M |
| Year 3 | $309.6M | $7.7M | 2.0% | $-5.4M | $-4.1M |
| Year 4 | $318.9M | $9.5M | 3.0% | $-4.4M | $-3.0M |
| Year 5 | $328.5M | $10.6M | 3.0% | $-3.9M | $-2.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-59.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$283.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00012975948159283613
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5